Q2 2017 Holdings
Filed 2017-07-19 | 9 holdings | $41.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc.(ACRS) | Common Stock | 00461U105 | $41.8M | 1,539,480 | 99.7% |
| Spark Therapeutics, Inc. | Common Stock | 84652J103 | $41.4K | 693,128 | 0.1% |
| ObsEva SA | Common Stock | H5861P103 | $32.1K | 3,749,623 | 0.1% |
| Versartis, Inc. | Common Stock | 92529L102 | $27.3K | 1,563,260 | 0.1% |
| Natera, Inc.(NTRA) | Common Stock | 632307104 | $16.8K | 1,550,280 | 0.0% |
| Auris Medical Holding AG | Common Shares | H03579101 | $5.6K | 7,818,175 | 0.0% |
| Mirna Therapeutics, Inc. | Common Stock | 60470J103 | $5.0K | 2,974,812 | 0.0% |
| Innocoll Holdings PLC | Ordinary Shares | G4783X105 | $4.8K | 2,103,173 | 0.0% |
| Histogenics Corporation | Common Stock | 43358V109 | $3.7K | 2,077,040 | 0.0% |